Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees

被引：0
|
作者：
Huang, Jennifer Jing
Liang, Emily C.
Albittar, Aya
Portuguese, Andrew Jay
Wuliji, Natalie
Torkelson, Aiko
Kirchmeier, Delaney
Chutnik, Abigail
Pender, Barbara
Shadman, Mazyar
Hirayama, Alexandre V.
Till, Brian G.
Kimble, Erik Lesley
Iovino, Lorenzo
Chapuis, Aude
Otegbeye, Folashade
Cassaday, Ryan Daniel
Milano, Filippo
Maloney, David G.
Gauthier, Jordan
机构：
[1] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7034
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up
    Mueller, Fabian
    Taubmann, Jule
    Bucci, Laura
    Wilhelm, Artur
    Bergmann, Christina
    Voelkl, Simon
    Aigner, Michael
    Rothe, Tobias
    Minopoulou, Ioanna
    Tur, Carlo
    Knitza, Johannes
    Kharboutli, Soraya
    Kretschmann, Sascha
    Vasova, Ingrid
    Spoerl, Silvia
    Reimann, Hannah
    Munoz, Luis
    Gerlach, Roman G.
    Schaefer, Simon
    Grieshaber-Bouyer, Ricardo
    Korganow, Anne-Sophie
    Farge-Bancel, Dominique
    Mougiakakos, Dimitrios
    Bozec, Aline
    Winkler, Thomas
    Kroenke, Gerhard
    Mackensen, Andreas
    Schett, Georg
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (08): : 687 - 700
  • [32] Lymphodepleting Chemotherapy before CD19 Directed CAR T-Cell Therapy: Are 3 Days Necessary?
    Geer, Marcus
    Kasha, Salena
    Frame, David
    Ghosh, Monalisa
    BLOOD, 2022, 140 : 3823 - 3824
  • [33] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 821 - 824
  • [34] Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
    Wen-ying Zhang
    Yang Liu
    Yao Wang
    Jing Nie
    Ye-lei Guo
    Chun-meng Wang
    Han-ren Dai
    Qing-ming Yang
    Zhi-qiang Wu
    Wei-dong Han
    Gene Therapy, 2018, 25 : 198 - 204
  • [35] Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
    Zhang, Wen-ying
    Liu, Yang
    Wang, Yao
    Nie, Jing
    Guo, Ye-lei
    Wang, Chun-meng
    Dai, Han-ren
    Yang, Qing-ming
    Wu, Zhi-qiang
    Han, Wei-dong
    GENE THERAPY, 2018, 25 (03) : 198 - 204
  • [36] Phase 2 Study of CD19 CAR T Cells with a Fully Human Binder for Large B-Cell Lymphoma in Relapse or Progression after a Murine Binder-Bearing CD19 CAR T-Cell Therapy
    Gauthier, Jordan
    Huang, Jennifer J.
    Jaeger-Ruckstuhl, Carla
    Liang, Emily C.
    Albittar, Aya
    Portuguese, Andrew J.
    Wu, Qian
    Torkelson, Aiko
    Kirchmeier, Delaney
    Chutnik, Abigail
    Pender, Barbara
    Shadman, Mazyar
    Hirayama, Alexandre V.
    Till, Brian G.
    Kimble, Erik L.
    Iovino, Lorenzo
    Chapuis, Aude G.
    Otegbeye, Folashade
    Cassaday, Ryan D.
    Milano, Filippo
    Poh, Christina
    Gopal, Ajay K.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2023, 142
  • [37] Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
    Friedes, Barbara D.
    Dino, Amanda M.
    Iannone, Emma
    Li, Yimei
    Rheingold, Susan R.
    Leahy, Allison Barz
    Wray, Lisa
    Callahan, Colleen
    Baniewicz, Diane
    Vernau, Lauren
    Getz, Kelly D.
    Aplenc, Richard
    Maude, Shannon L.
    Grupp, Stephan A.
    Myers, Regina M.
    BLOOD ADVANCES, 2025, 9 (02) : 354 - 359
  • [38] Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia
    Dekker, Linde
    Calkoen, Friso G.
    Jiang, Yilin
    Blok, Hilly
    Veldkamp, Saskia R.
    De Koning, Coco
    Spoon, Maike
    Admiraal, Rick
    Hoogerbrugge, Peter
    Vormoor, Britta
    Vormoor, H. Josef
    Visscher, Henk
    Bierings, Marc
    Van der Vlugt, Marieke
    Van Tinteren, Harm
    Nijstad, A. Laura
    Huitema, Alwin D. R.
    Van der Elst, Kim C. M.
    Pieters, Rob
    Lindemans, Caroline A.
    Nierkens, Stefan
    BLOOD ADVANCES, 2022, 6 (07) : 1969 - 1976
  • [39] Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
    Dahiya, Saurabh
    Luetkens, Tim
    Lutfi, Forat
    Avila, Stephanie
    Iraguha, Thierry
    Margiotta, Philip
    Hankey, Kim G.
    Lesho, Patricia
    Law, Jennie Y.
    Lee, Seung T.
    Baddley, John
    Kocoglu, Mehmet
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Atanackovic, Djordje
    BLOOD ADVANCES, 2022, 6 (02) : 686 - 689
  • [40] High IL-15 Serum Concentrations Are Associated with Response to CD19 CAR T-Cell Therapy and Robust In Vivo CAR T-Cell Kinetics
    Gauthier, Jordan
    Chou, Cassie
    Hirayama, Alexandre V.
    Fiorenza, Salvatore
    Sheih, Alyssa
    Pender, Barbara S.
    Tinh-Doan Phi
    Steinmetz, Rachel
    Jamieson, Abby
    Kirchmeier, Delaney R.
    Di, Henna N.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2020, 136
12345